Company
Lantheus Biosciences Ltd.
Lantheus Biosciences Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Florbetaben (BAY94-9172) | Phase 3 | Alzheimer Disease |
Latest
No recent events.
Follow Lantheus Biosciences Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.